Canaccord analyst Derek Dley lowered the firm’s price target on Trulieve Cannabis (TCNNF) to C$32 from C$38 and keeps a Buy rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCNNF:
- Rising High: Exclusive talk with house of brands Carma HoldCo
- Trulieve Cannabis downgraded to Market Perform from Speculative Buy at Cormark
- Trulieve Cannabis Reports Steady Growth Amid Challenges
- Trulieve Cannabis Reports Revenue Growth Amid Expansion
- TCNNF Upcoming Earnings Report: What to Expect?